Simplify the Management of Antithrombotics for Valvular Heart Disease

We're getting questions about managing antithrombotics in patients with valvular heart disease...due to recent Am Heart Assn guidelines.

Who needs an antithrombotic? Continue to use an anticoagulant for most patients with a prosthetic heart valve.

Antiplatelet meds...such as clopidogrel for 6 months plus lifelong aspirin 81 mg/day...are an alternative for patients with transcatheter aortic valve replacement (TAVR). TAVR is similar to a cardiac stent...a new valve is placed with a catheter, which "takes over" for the old one.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote